post-transplant lymphoproliferative disorder

Also found in: Wikipedia.

post-transplant lymphoproliferative disorder

A family of Epstein-Barr virus-associated lymphoid expansions with a range of histologies, from infectious mononucleosis-like lymphoid hyperplasia to monoclonal neoplasms, that may not be classifiable as specific types of non-Hodgkin lymphoma, even if typical genetic defects are present. Monoclonal post-transplant lymphoproliferative disorders (PTLDs) do not regress when immunosuppression is withdrawn. PTLD occurs in 1–10% of organ transplant recipients; most cases that occur in solid organ recipients are of host origin.

Diagnosis
Post-transplant patients at risk for PTLD can be identified by detecting expression (as small mRNA) of the EBER-1 gene.

Note
Malignant features may regress with reduced immunosuppression.

Mentioned in ?

References in periodicals archive ?

Burnett adds that while his caution for the company's MS program is in line with consensus view, he believes the Street is "missing" that success in post-transplant lymphoproliferative disorder study would "validate" its HLA approach.

Atara Biotherapeutics initiated with a Buy at Stifel

The United States Food and Drug Administration (FDA) has granted Orphan Drug Designations (ODD) to United States-based Viracta Therapeutics, Incorporated's Phase two drug candidate, nanatinostat, in combination with the antiviral valganciclovir intended for the treatment of post-transplant lymphoproliferative disorder (PTLD), plasmablastic lymphoma, and angioimmunoblastic T cell lymphoma, it was reported yesterday.

US FDA grants Orphan Drug Designation to Viracta Therapeutics' cancer drug nanatinostat

Post-transplant lymphoproliferative disorder - the potential of proliferation signal inhibitors.

Post-transplant malignancies in pediatric liver transplant recipients: Experience of two centers in Turkey

Magee, "Limitations of EBV-PCR monitoring to detect EBV associated post-transplant lymphoproliferative disorder," Pediatric Transplantation, vol.

Posttransplant Lymphoproliferative Disorder Presenting as Testicular Lymphoma in a Kidney Transplant Recipient: A Case Report and Review of the Literature

Harmon, "Post-transplant lymphoproliferative disorder in the United States: Young Caucasian males are at highest risk," American Journal of Transplantation, vol.

Unusual Case of Severe Lactic Acidosis in a Liver Transplant Patient

Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience.

Immunosuppressive drugs and major complications in pediatric renal transplantation/Inmunosupresores y principales complicaciones en el trasplante renal pediatrico/Imunossupressores e principais complicacoes no transplante renal pediatrico

Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis.

Tratamiento de la enfermedad linfoproliferativa post-trasplante renal con rituximab y conversion a inhibidor m-TOR

Cell Medica, a leader in developing, marketing and manufacturing cellular therapeutics for cancer and viral infections, has received European Commission orphan drug designations for CMD-003 (baltaleucel-T) as a treatment for extranodal NK/T-cell lymphoma, nasal type, and post-transplant lymphoproliferative disorder.

United Kingdom : Lead cancer immunotherapy candidate granted EU orphan drug designations

Leblond et al., "Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial," The Lancet Oncology, vol.

Fc[gamma]-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive posttransplant lymphoproliferative disorder

The virus can then reawaken and drive the development of B cell cancers like AIDS-associated B cell lymphoma and post-transplant lymphoproliferative disorder.

Single Protein Helps Body Keep Watch over Epstein-Barr Virus

But while recovering from the transplant, a PET scan revealed she had developed post-transplant lymphoproliferative disorder (PTLD), a condition which can lead to cancer.

Scanner can detect tiniest cancer traces

* Those also occurring in other immunodeficiency states such as post-transplant lymphoproliferative disorder. (11)

HIV-associated malignancies have become increasingly important with the spread of HIV infection